PPD, Inc.

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments: clinical development services and laboratory services. It offers clinical development services, including product development and consulting, early development, Phase II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services, including bioanalytical, biomarker, vaccine science, good manufacturing practices, and central laboratory services. It serves consumer health, medical device development, PPD biotech solutions, and government and public health organizations. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is based in Wilmington, North Carolina. As of December 8, 2021, PPD, Inc. operates as a subsidiary of Thermo Fisher Scientific Powder Us Holdings Corp.